Daiichi Sankyo Company, Limited (DSKYF)
OTCMKTS · Delayed Price · Currency is USD
18.91
-0.65 (-3.32%)
Jan 30, 2026, 4:00 PM EST
Daiichi Sankyo Company Market Cap
Daiichi Sankyo Company has a market cap or net worth of $34.87 billion as of February 3, 2026. Its market cap has decreased by -32.25% in one year.
Market Cap
34.87B
Enterprise Value
33.32B
Revenue
13.09B
Ranking
n/a
PE Ratio
17.95
Stock Price
$18.91
Market Cap Chart
Since September 28, 2005, Daiichi Sankyo Company's market cap has increased from 2.93B to 34.87B, an increase of 1,091.68%. That is a compound annual growth rate of 12.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 34.65B | -12.62% |
| Dec 30, 2025 | 39.66B | -23.97% |
| Dec 30, 2024 | 52.16B | -0.97% |
| Dec 29, 2023 | 52.67B | -14.75% |
| Dec 30, 2022 | 61.78B | 26.88% |
| Dec 30, 2021 | 48.69B | -26.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 816.06M |
| Glass House Brands | 768.48M |
| Northwest Biotherapeutics | 462.76M |
| Elite Pharmaceuticals | 451.27M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| CytoDyn | 320.56M |
| OpGen | 243.57M |